Pnc Financial Services Group, Inc. Cassava Sciences Inc Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 116 shares of SAVA stock, worth $267. This represents 0.0% of its overall portfolio holdings.
Number of Shares
116
Previous 2,338
95.04%
Holding current value
$267
Previous $68,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding SAVA
# of Institutions
189Shares Held
13.4MCall Options Held
2.96MPut Options Held
6.55M-
Black Rock Inc. New York, NY3.22MShares$7.44 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$5.81 Million0.0% of portfolio
-
State Street Corp Boston, MA1.16MShares$2.69 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$2.33 Million0.0% of portfolio
-
Morgan Stanley New York, NY520KShares$1.2 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $92.6M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...